337 related articles for article (PubMed ID: 17916800)
1. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses.
Tomchuck SL; Zwezdaryk KJ; Coffelt SB; Waterman RS; Danka ES; Scandurro AB
Stem Cells; 2008 Jan; 26(1):99-107. PubMed ID: 17916800
[TBL] [Abstract][Full Text] [Related]
2. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.
Waterman RS; Tomchuck SL; Henkle SL; Betancourt AM
PLoS One; 2010 Apr; 5(4):e10088. PubMed ID: 20436665
[TBL] [Abstract][Full Text] [Related]
3. IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells.
Böcker W; Docheva D; Prall WC; Egea V; Pappou E; Rossmann O; Popov C; Mutschler W; Ries C; Schieker M
J Mol Med (Berl); 2008 Oct; 86(10):1183-92. PubMed ID: 18600306
[TBL] [Abstract][Full Text] [Related]
4. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium.
Gao H; Priebe W; Glod J; Banerjee D
Stem Cells; 2009 Apr; 27(4):857-65. PubMed ID: 19350687
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.
Liotta F; Angeli R; Cosmi L; Filì L; Manuelli C; Frosali F; Mazzinghi B; Maggi L; Pasini A; Lisi V; Santarlasci V; Consoloni L; Angelotti ML; Romagnani P; Parronchi P; Krampera M; Maggi E; Romagnani S; Annunziato F
Stem Cells; 2008 Jan; 26(1):279-89. PubMed ID: 17962701
[TBL] [Abstract][Full Text] [Related]
6. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
[TBL] [Abstract][Full Text] [Related]
7. TLR-induced immunomodulatory cytokine expression by human gingival stem/progenitor cells.
Mekhemar MK; Adam-Klages S; Kabelitz D; Dörfer CE; Fawzy El-Sayed KM
Cell Immunol; 2018 Apr; 326():60-67. PubMed ID: 28093098
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.
Opitz CA; Litzenburger UM; Lutz C; Lanz TV; Tritschler I; Köppel A; Tolosa E; Hoberg M; Anderl J; Aicher WK; Weller M; Wick W; Platten M
Stem Cells; 2009 Apr; 27(4):909-19. PubMed ID: 19353519
[TBL] [Abstract][Full Text] [Related]
9. Cultured human melanocytes express functional toll-like receptors 2-4, 7 and 9.
Yu N; Zhang S; Zuo F; Kang K; Guan M; Xiang L
J Dermatol Sci; 2009 Nov; 56(2):113-20. PubMed ID: 19740627
[TBL] [Abstract][Full Text] [Related]
10. Role of toll-like receptors on human adipose-derived stromal cells.
Hwa Cho H; Bae YC; Jung JS
Stem Cells; 2006 Dec; 24(12):2744-52. PubMed ID: 16902195
[TBL] [Abstract][Full Text] [Related]
11.
Jeske R; Yuan X; Fu Q; Bunnell BA; Logan TM; Li Y
Front Immunol; 2021; 12():621744. PubMed ID: 33777002
[TBL] [Abstract][Full Text] [Related]
12. Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway?
Iskender B; Izgi K; Sakalar C; Canatan H
Tumour Biol; 2016 Feb; 37(2):1967-81. PubMed ID: 26334623
[TBL] [Abstract][Full Text] [Related]
13. Low-level shear stress induces human mesenchymal stem cell migration through the SDF-1/CXCR4 axis via MAPK signaling pathways.
Yuan L; Sakamoto N; Song G; Sato M
Stem Cells Dev; 2013 Sep; 22(17):2384-93. PubMed ID: 23544621
[TBL] [Abstract][Full Text] [Related]
14. Wnt signaling regulates the invasion capacity of human mesenchymal stem cells.
Neth P; Ciccarella M; Egea V; Hoelters J; Jochum M; Ries C
Stem Cells; 2006 Aug; 24(8):1892-903. PubMed ID: 16690780
[TBL] [Abstract][Full Text] [Related]
15. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
[TBL] [Abstract][Full Text] [Related]
16. miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells.
Tomé M; López-Romero P; Albo C; Sepúlveda JC; Fernández-Gutiérrez B; Dopazo A; Bernad A; González MA
Cell Death Differ; 2011 Jun; 18(6):985-95. PubMed ID: 21164520
[TBL] [Abstract][Full Text] [Related]
17. CD9 Upregulation-Decreased CCL21 Secretion in Mesenchymal Stem Cells Reduces Cancer Cell Migration.
Hsieh CC; Hsu SC; Yao M; Huang DM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572290
[TBL] [Abstract][Full Text] [Related]
18. The DLC-1 tumor suppressor is involved in regulating immunomodulation of human mesenchymal stromal /stem cells through interacting with the Notch1 protein.
Na T; Zhang K; Yuan BZ
BMC Cancer; 2020 Nov; 20(1):1064. PubMed ID: 33148199
[TBL] [Abstract][Full Text] [Related]
19. Forkhead box O1 (FOXO1) controls the migratory response of Toll-like receptor (TLR3)-stimulated human mesenchymal stromal cells.
Kim SH; Das A; Choi HI; Kim KH; Chai JC; Choi MR; Binas B; Park KS; Lee YS; Jung KH; Chai YG
J Biol Chem; 2019 May; 294(21):8424-8437. PubMed ID: 30944148
[TBL] [Abstract][Full Text] [Related]
20. Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells.
Kumar MV; Nagineni CN; Chin MS; Hooks JJ; Detrick B
J Neuroimmunol; 2004 Aug; 153(1-2):7-15. PubMed ID: 15265658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
